Strategy for standardization of preeclampsia research study design

Hypertension

Volumn 63, Issue 6, 2014, Pages 1293-1301

  Myatt, Leslie ^a   Redman, Christopher W ^b   Staff, Anne Cathrine ^c   Hansson, Stefan ^d   Wilson, Melissa L ^e   Laivuori, Hannele ^f   Poston, Lucilla ^g   Roberts, James M ^h  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF HELSINKI   (Finland)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Hypertension; Placenta; Pre eclampsia; Pregnancy; Proteinuria

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DISEASE CLASSIFICATION; FEMALE; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; INFORMATION PROCESSING; MATERNAL HYPERTENSION; MATERNAL SMOKING; OBESITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SEX DIFFERENCE; STANDARDIZATION; STUDY DESIGN; SYNDROME;

HYPERTENSION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; FEMALE; GESTATIONAL AGE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PRE-ECLAMPSIA; PREGNANCY; REFERENCE STANDARDS; RESEARCH DESIGN; ULTRASONOGRAPHY, PRENATAL;

EID: 84902273313     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02664     Document Type: Article

References (22)

1. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99:547-553.
2. Tang LC, Kwok AC, Wong AY, Lee YY, Sun KO, So AP. Critical care in obstetrical patients: an eight-year review. Chin Med J (Engl). 1997;110:936-941.
3. Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195:1557-1563.
4. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200-1204.
5. Cnossen JS, ter Riet G, Mol BW, van der Post JA, Leeflang MM, Meads CA, Hyde C, Khan KS. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand. 2009;88:758-765.
6. Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol. 2002;155:203-209.
7. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166-171.
8. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323:1213-1217.
9. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.
10. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension. 2005;46:1263-1269.
11. Powers RW, Catov JM, Bodnar LM, Gallaher MJ, Lain KY, Roberts JM. Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome. Reprod Sci. 2008;15:374-381.
12. Rana S, Karumanchi SA, Lindheimer MD. Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension. 2014;63:198-202.
13. Chesley LC. History and epidemiology of preeclampsia-eclampsia. Clin Obstet Gynecol. 1984;27:801-820.
14. Homer CSE, Brown MA, Mangos G, Davis GK. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens. 2008;26:295-302.
15. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, Klebanoff M, Vandorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002;186:66-71.
16. Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122-1131.
17. Spong CY. Defining "term" pregnancy: recommendations from the Defining "Term" Pregnancy Workgroup. JAMA. 2013;309:2445-2446.
18. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;14:368-374.
19. Xiong X, Wang FL, Davidge ST, Demianczuk NN, Mayes DC, Olson DM, Saunders LD. Maternal smoking and preeclampsia. J Reprod Med. 2000;45:727-732.
20. Vatten LJ, Skjaerven R. Offspring sex and pregnancy outcome by length of gestation. Early Hum Dev. 2004;76:47-54.
21. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
22. Burton GJ, Sebire NJ, Myatt L, Tannetta D, Wang YL, Sadovsky Y, Staff AC, Redman CW. Optimising sample collection for placental research. Placenta. 2014;35:9-22.